<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26709272</article-id>
      <article-id pub-id-type="pmc">4713858</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2016.36.2.188</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Clinical Chemistry</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ascorbate Oxidase Minimizes Interference by High-Concentration Ascorbic Acid in Total Cholesterol Assays</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nah</surname>
            <given-names>Hyunjin</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yim</surname>
            <given-names>Jisook</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Sang-Guk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Jong-Baeck</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Jeong-Ho</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Laboratory Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Jisook Yim. Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: +82-2-2228-2453, Fax: +82-2-364-1583, <email>karenwalker@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>36</volume>
      <issue>2</issue>
      <fpage>188</fpage>
      <lpage>190</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>Ascorbic acid interferes with certain clinical chemistry assays based on peroxidase and redox indicators [<xref rid="B1" ref-type="bibr">1</xref>]. Ascorbic acid is reported to interfere with the measurement of glucose, total cholesterol, triglycerides, and uric acid [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref>]. We recently encountered several cases of interference from ascorbic acid in serum total cholesterol assays based on colorimetric enzymatic reactions.</p>
    <p>A 48-yr-old-female with recurrent ovarian cancer underwent palliative segmental resection surgery of the small intestine. The patient showed progressive renal impairment following surgery, and total cholesterol level was &lt;3 mg/dL, as measured using the OSR6516 total cholesterol assay (Beckman Coulter, Brea, CA, USA) on an AU5800 analyzer (Beckman Coulter). We repeated the test with the same sample, using the Pureauto S CHO-N total cholesterol assay (Sekisui Medical Co., Tokyo, Japan) on a Hitachi7600 analyzer (Hitachi Co., Tokyo, Japan) and observed a concentration of 121 mg/dL. We did not repeat the OSR6516 assay after a certain period. The specimen was checked for lipemic, hemolytic, and icteric indices to rule out other possible interferents. The patient was administered 30 g of ascorbic acid intravenously daily for 22 days prior to total cholesterol measurements. Dipstick analysis of the patient's urine was performed by using an URiSCAN SUPER analyzer (YD Diagnostics, Seoul, Korea), which showed a value of 2+ (equivalent to 25 mg/dL) for ascorbic acid. Three additional cases characterized by spuriously low total cholesterol values owing to ascorbic acid interference are summarized in <xref ref-type="table" rid="T1">Table 1</xref>. Although we could not determine serum ascorbic acid levels, we detected its presence by using a urine dipstick assay in three of the four cases.</p>
    <p>Several studies recommend the addition of ascorbate oxidase to minimize ascorbic acid interference in assays to assess uric acid, triglyceride, oxalate, and cholesterol [<xref rid="B5" ref-type="bibr">5</xref><xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref>]. Most cholesterol assays in clinical laboratories use an enzymatic colorimetric method with the Trinder end-point reaction, in which hydrogen peroxide reacts with a chromogen via peroxidase to form a colored product; absorbance of this product is proportional to the concentration of total cholesterol in the sample [<xref rid="B1" ref-type="bibr">1</xref>]. Ascorbic acid interferes with peroxidase-based oxidation of the chromogen [<xref rid="B6" ref-type="bibr">6</xref>]. Since dehydroascorbic acid is already oxidized and has lost its reducing power, interference via ascorbic acid can be successfully prevented. Commercially available total cholesterol assays are summarized in <xref ref-type="table" rid="T2">Table 2</xref>. Ascorbate oxidase included in the Sekisui total cholesterol assay effectively converts serum ascorbic acid (up to concentrations of 50 mg/dL) to dehydroascorbic acid.</p>
    <p>Since ascorbic acid rapidly auto-oxidizes over time, it is difficult to detect its interference in cholesterol measurements [<xref rid="B3" ref-type="bibr">3</xref><xref rid="B9" ref-type="bibr">9</xref>]. Reviewing medical records can also be problematic; some ascorbic acid supplements are not physician-prescribed but are readily available over-the-counter. Furthermore, it is difficult to predict serum ascorbic acid concentrations based on ingested doses of ascorbic acid in patients with impaired renal function.</p>
    <p>Artiss et al. [<xref rid="B9" ref-type="bibr">9</xref>] suggested that we can exclude ascorbate oxidase in wet-chemistry reagent systems for cholesterol determination because solvated ascorbic acid is subject to air oxidation. Thus, the interfering substance is oxidized prior to analysis by laboratory instruments. This is partly true for most samples from patients whose renal function is intact and for those consuming typical ascorbic acid doses. It might be particularly problematic for patients with impaired renal function or for those taking high ascorbic acid doses. In the second case (<xref ref-type="table" rid="T1">Table 1</xref>), we presumed that this low cholesterol level was likely due to ascorbic acid accumulation in the blood owing to impaired renal function, even though the prescribed dose of ascorbic acid was not high.</p>
    <p>As all of our cases showed extremely low total cholesterol levels, the laboratory technician easily noticed analytical errors and tried to troubleshoot them before reporting the results. These problems occurred in approximately one case bimonthly and were reported to managers and documented. However, interference from low concentrations of ascorbic acid causes a small negative bias in total cholesterol levels, which may go unnoticed. Ascorbic acid is one of the most widely consumed nutritional supplements, and some physicians prescribe megadoses for cancer therapy [<xref rid="B10" ref-type="bibr">10</xref>]. Consequently, managers of clinical laboratories should consider the use of cholesterol assays that include ascorbate oxidase.</p>
    <p>In conclusion, when colorimetric enzymatic assays detect inappropriately low levels of total cholesterol, we should suspect ascorbic acid interference. Addition of ascorbate oxidase to cholesterol reagents can minimize the inference of ascorbic acid in total cholesterol assays.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White-Stevens</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Stover</surname>
              <given-names>LR</given-names>
            </name>
          </person-group>
          <article-title>Interference by ascorbic acid in test systems involving peroxidase. II. Redox-coupled indicator systems</article-title>
          <source>Clin Chem</source>
          <year>1982</year>
          <volume>28</volume>
          <fpage>589</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="pmid">7074825</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Badrick</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Effects of intravenous infusion of ascorbate on common clinical chemistry tests</article-title>
          <source>Clin Chem</source>
          <year>1992</year>
          <volume>38</volume>
          <fpage>2160</fpage>
          <pub-id pub-id-type="pmid">1395019</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinello</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>Ascorbic acid interference in the measurement of serum biochemical parameters: in vivo and in vitro studies</article-title>
          <source>Clin Biochem</source>
          <year>2006</year>
          <volume>39</volume>
          <fpage>396</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="pmid">16403487</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meng</surname>
              <given-names>QH</given-names>
            </name>
            <name>
              <surname>Irwin</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Fesser</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Massey</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Interference of ascorbic acid with chemical analytes</article-title>
          <source>Ann Clin Biochem</source>
          <year>2005</year>
          <volume>42</volume>
          <fpage>475</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="pmid">16259800</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freemantle</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Freemantle</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Badrick</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Ascorbate interferences in common clinical assays performed on three analyzers</article-title>
          <source>Clin Chem</source>
          <year>1994</year>
          <volume>40</volume>
          <fpage>950</fpage>
          <lpage>951</lpage>
          <pub-id pub-id-type="pmid">8087995</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rolton</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>McConnell</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Modi</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Macdougall</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>A simple, rapid assay for plasma oxalate in uraemic patients using oxalate oxidase, which is free from vitamin C interference</article-title>
          <source>Clin Chim Acta</source>
          <year>1989</year>
          <volume>182</volume>
          <fpage>247</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">2766549</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lumb</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Slavin</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Determination of serum cholesterol concentration in the presence of ascorbate</article-title>
          <source>J Clin Pathol</source>
          <year>1993</year>
          <volume>46</volume>
          <fpage>283</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="pmid">8463427</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinello</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Luiz da Silva</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Mechanism of ascorbic acid interference in biochemical tests that use peroxide and peroxidase to generate chromophore</article-title>
          <source>Clin Chim Acta</source>
          <year>2006</year>
          <volume>373</volume>
          <fpage>108</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">16806141</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Artiss</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Zak</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <chapter-title>Measurement of cholesterol concentration</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Rifai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Warnick</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Dominiczak</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <source>Handbook of lipoprotein testing</source>
          <edition>2nd ed</edition>
          <publisher-loc>Washington D.C.</publisher-loc>
          <publisher-name>AACC Press</publisher-name>
          <year>2000</year>
          <fpage>196</fpage>
          <lpage>197</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riordan</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Riordan</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent</article-title>
          <source>Med Hypotheses</source>
          <year>1995</year>
          <volume>44</volume>
          <fpage>207</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="pmid">7609676</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Summary of the four cases with inappropriately low total cholesterol level</title>
      </caption>
      <alternatives>
        <graphic xlink:href="alm-36-188-i001"/>
        <table frame="hsides" rules="rows">
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="1" colspan="1">Case No.</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Age (yr)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Sex</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Diagnosis</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">eGFR<sup>*</sup> (mL/min/1.73 m<sup>2</sup>)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">ascorbic acid supplementation history</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Initial total cholesterol assay</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Initial serum total cholesterol level (mg/dL)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Subsequent total cholesterol assay</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Subsequent serum total cholesterol level (mg/dL)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Urine dipstick analysis for ascorbic acid</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">48</td>
              <td valign="top" align="center" rowspan="1" colspan="1">F</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
              <td valign="top" align="center" rowspan="1" colspan="1">11</td>
              <td valign="top" align="left" rowspan="1" colspan="1">30 g IV one time per day for 22 days</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Beckman Coulter/AU5800<sup>&#x2020;</sup></td>
              <td valign="top" align="left" rowspan="1" colspan="1">&lt; 3 (0.5 hr<sup>&#xA7;</sup>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Sekisui/Hitachi 7600<sup>&#x2225;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">121</td>
              <td valign="top" align="left" rowspan="1" colspan="1">2+<sup>&#xB6;</sup> (1.5 hr<sup>**</sup>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">91</td>
              <td valign="top" align="center" rowspan="1" colspan="1">M</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Bladder cancer</td>
              <td valign="top" align="center" rowspan="1" colspan="1">23</td>
              <td valign="top" align="left" rowspan="1" colspan="1">40 mg PO 4 times per day for 2 weeks</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Roche/Cobas c701<sup>&#x2021;</sup></td>
              <td valign="top" align="left" rowspan="1" colspan="1">&lt; 4 (6 hr<sup>&#xA7;</sup>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Sekisui/Hitachi 7600<sup>&#x2225;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">94</td>
              <td valign="top" align="left" rowspan="1" colspan="1">N/A<sup>&#x2020;&#x2020;</sup> (N/A<sup>**</sup>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">89</td>
              <td valign="top" align="center" rowspan="1" colspan="1">M</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Diabetes mellitus</td>
              <td valign="top" align="center" rowspan="1" colspan="1">85</td>
              <td valign="top" align="left" rowspan="1" colspan="1">20 g IV one time per day for 19 days</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Beckman Coulter/AU5800<sup>&#x2020;</sup></td>
              <td valign="top" align="left" rowspan="1" colspan="1">&lt; 3 (3 hr<sup>&#xA7;</sup>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Sekisui/Hitachi 7600<sup>&#x2225;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">97</td>
              <td valign="top" align="left" rowspan="1" colspan="1">2+<sup>&#xB6;</sup> (3 days<sup>**</sup>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">80</td>
              <td valign="top" align="center" rowspan="1" colspan="1">M</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Pancreatic cancer</td>
              <td valign="top" align="center" rowspan="1" colspan="1">14</td>
              <td valign="top" align="left" rowspan="1" colspan="1">N/A</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Beckman Coulter/AU5800<sup>&#x2020;</sup></td>
              <td valign="top" align="left" rowspan="1" colspan="1">&lt; 3 (N/A<sup>&#xA7;</sup>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Sekisui/Hitachi 7600<sup>&#x2225;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">95</td>
              <td valign="top" align="left" rowspan="1" colspan="1">3+<sup>&#xB6;</sup> (4 hr<sup>**</sup>)</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>eGFR was calculated by using 2009 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equations currently recommended by The National Kidney Foundation. No patients had dialysis history; <sup>&#x2020;</sup>OSR6516 Cholesterol assay (Beckman Coulter, Inc., Brea, CA, USA) on the AU5800 Clinical Chemistry System (Beckman Coulter, Inc.); <sup>&#x2021;</sup>CHOL2 (Roche Diagnostics GmbH, Mannheim, Germany) assay on the Cobas c701 Analyzer (Roche Diagnostics GmbH); <sup>&#xA7;</sup>Time interval between the most recent ascorbic acid administration and total cholesterol measurement; <sup>&#x2225;</sup>Pureauto S CHO-N (Sekisui Medical Co., Ltd., Tokyo, Japan) assay on the Hitachi 7600 Analyzer (Hitachi Co., Tokyo, Japan); <sup>&#xB6;</sup>The urine dipstick analyses for cases 1, 3, and 4 were performed using the URiSCAN SUPER analyzer (YD Diagnostics, Seoul, Korea). In the urine dipstick analysis for ascorbic acid, -, 1+, 2+, and 3+ are equivalent to ascorbic acid concentrations of negative, 10 mg/dL, 25 mg/dL, and 50 mg/dL, respectively; <sup>**</sup>Time interval between total cholesterol measurement and urine analysis; <sup>&#x2020;&#x2020;</sup>Since the ascorbic acid item is not included in the CLINITEK Novus (Siemens Healthcare Diagnostics Inc., Erlangen, Germany) urine dipstick analysis strip, the urine ascorbic acid concentration of the patient from case 2 could not be measured.</p>
          <p>Abbreviations: eGFR, estimated glomerular filtration rate; F, female; M, male; PO, <italic>per os</italic> or oral administration; IV, intravenously; N/A, not available.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <title>Summary of commercially available total cholesterol assays with respect to the presence of ascorbate oxidase</title>
      </caption>
      <alternatives>
        <graphic xlink:href="alm-36-188-i002"/>
        <table frame="hsides" rules="rows">
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="1" colspan="1">Total cholesterol assays<sup>*</sup></th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Ascorbate oxidase in the list of ingredients</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Description of ascorbic acid interference by manufacturer</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">OSR6516 Cholesterol (Beckman Coulter, Inc., Brea, CA, USA)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="left" rowspan="1" colspan="1">No significant interference (within&#xB1;10.0 mg/dL) up to 3 mg/dL</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">CHOL (Beckman Coulter, Inc., Brea, CA, USA)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="left" rowspan="1" colspan="1">No significant interference (within&#xB1;10.0 mg/dL) up to 3 mg/dL</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">CHOL2 (Roche Diagnostics GmbH, Mannheim, Germany)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Not shown</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">CHOLESTEROL (Abbott Laboratories, Chicago, IL, USA)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Observed % of target: 97.6% at 3 mg/dL of ascorbic acid</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Pureauto S CHO-N (Sekisui Medical Co., Ltd., Tokyo, Japan)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="left" rowspan="1" colspan="1">No ascorbic acid interference up to 50 mg/dL</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Wako L Type CHO M (Wako Pure Chemical Industries, Ltd., Osaka, Japan)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="left" rowspan="1" colspan="1">No significant effects</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">SEIKEN T-CHO (S) (Denka Seiken Co., Ltd., Niigata, Japan)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="left" rowspan="1" colspan="1">No interference up to 50 mg/dL</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Determiner C-TC (Kyowa Medex Co., Ltd., Tokyo, Japan)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="left" rowspan="1" colspan="1">May negatively affect measurement if their concentrations in blood are high</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>The total cholesterol assays listed are all based on colorimetric enzymatic reactions with the Trinder reaction end-point.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
